Pfizer Escapes FCA Suit Over Anti-Fungal Drug Promotions

Law360, Los Angeles (November 25, 2013, 8:38 PM EST) -- A Massachusetts federal judge on Friday dismissed an ex-Pfizer Inc. manager's False Claims Act qui tam suit accusing the drug giant of a long-running and illegal campaign to promote off-label use of anti-fungal drugs, finding the claims were too vague.

U.S. District Judge Nathaniel M. Gorton decided the claims were insufficient because they didn't contain enough details accusing Pfizer of submitting a false claim to the federal government over Vfend and Eraxis.

Paul Worsfold, a former district manager at Pfizer, said his ex-employer recklessly and unnecessarily...
To view the full article, register now.